An immune-modulating peptide that enhances innate and adaptive immunity, balancing autoimmune activity and accelerating recovery.
Product price :
Price range: د.إ 500.00 through د.إ 850.00
| Directions | SC injection, administered as directed. |
|---|---|
| Key Benefits | Enhances innate & adaptive immunity |
| Dose / Volume | Injectable 15,000mcg / 5ml vial, Injection Pen 9,000mcg / 3ml vial, Nasal Spray 10mg / 5ml bottle |
Thymosin Alpha-1 (Tα1) is a synthetic peptide derived from thymosin alpha-1, a naturally occurring peptide associated with the thymus and the regulation of immune-system activity. It has been researched for its potential immunomodulatory and immune-supporting effects.
Rather than simply stimulating the immune system, Thymosin Alpha-1 is thought to help regulate immune responses by influencing immune cells and signaling pathways. Research has examined its effects on T cells, dendritic cells, natural killer cells, and other components of the immune system.
Thymosin Alpha-1 has been studied in relation to:
Clinical and experimental research suggests that Tα1 may help modulate immune responses rather than simply increasing immune activity. This has made it particularly interesting in research involving infections and conditions where immune function may be impaired or dysregulated.
Thymosin Alpha-1 has been used and studied clinically in several countries, but its approved uses vary by country. Reported adverse effects are often relatively mild:
Individual risks can vary.
